Sunday, September 01, 2013 10:31:15 PM
Apparently, PF and EF are supposed to have this technology. At least that is what I read on these boards. However, Fuse can not advertise them as sublingual, so no one really knows how to take the product for it to have it's greatest effect. Why they can not advertise that is beyond me. Someone explained that they are not allowed to for some silly reason.
So, now we have Macular supposedly testing this same "technology". Will they be able to advertise their product as sublingual using Fuse's "technology"?
If its not taken sublingually so that it gets into the blood stream quicker and bypasses the GI, what's the point of the "technology"?
These are my opinions unless otherwise noted.
Proud member #2 of the "iHub 9". All CAPS will crush the whimpy girly man quotes!!!
http://www.pinksheets.com/otciq/ajax/showFinancialReportById.pdf?id=15992
FEATURED DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • Nov 7, 2024 2:16 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM